What`s holding you back??!, page-3

"ex vivo" application in the OR. Should be suitable for the next generation research instrument to be launched in 2016. Wouldn`t be the same sterility issues as with "in vivo".

https://cancerologyoncologysfakiana...ncer-based-on-human-liver-autofluorescence-2/

Increasing reimbursements for CLE use. The cost of health care finally starting to bite.

http://www.realtimecommunicationsworld.com/news/2016/11/03/8447997.htm

Endomicroscopy won`t be ignored much longer!!

http://www.nature.com/nrgastro/jour...ro.2016.148.html?WT.feed_name=subjects_cancer

"Lugol's chromoendoscopy remains the gold standard to identify squamous dysplasia. Identification and characterization of subtle neoplastic lesions could help to target biopsies and perform endoscopic resection for better local staging and definitive therapy. In vivo histology with techniques such as confocal endomicroscopy could make endotherapy feasible within a shorter timescale than when relying on histology on tissue samples."

The train is leaving the station.